How a pneumococcal vaccine’s HCP message deck was adapted for France, restructuring layers of claims to meet ANSM promotional requirements while maintaining scientific precision.
The client
A pharmaceutical manufacturer bringing a pneumococcal conjugate vaccine to the French market. The HCP message deck was designed for use by medical representatives in field-force interactions with physicians and specialists, covering its efficacy, safety, and patient population positioning.
The challenge
Vaccine HCP messaging for France operates within a specific promotional framework. ANSM guidelines and EU Directive 2001/83/EC govern what can be claimed, how efficacy data has to be framed, and the balance that has to be struck between benefit and risk claims.
An English TPP message deck structured for a global market can’t simply be carried directly over into French, as the architecture of the claim may be technically accurate, but structurally non-compliant for ANSM review.
The message deck had a layered structure: primary claims for headlines and sub-headings, secondary claims providing contextual support, and alternative formulations built in for representative flexibility. Every layer had to retain its rhetorical function in French while also conforming to ANSM framing requirements. A secondary claim that reads as a strong promotional statement in English may need to be reformulated in French to maintain the required balance between benefits and risks.
Register adds a further dimension, as the French had to work in conversation, being both natural enough to be spoken by a representative across a desk and precise enough to be clinically credible to the physician hearing it.
In the source file, alternative claim formulations were visually flagged using color to distinguish them from primary claims. The French adaptation preserved that structural distinction, with each claim layer being handled separately, rather than the deck being treated as one single continuous text.
The solution
The structure of the claim was reviewed in full before translation began. Primary and secondary claim functions were mapped against ANSM-compliant framing requirements, and alternative formulations in the source text were assessed for their regulatory standing in the French context before they were adapted.
The register was calibrated for field-force use throughout: formal enough to convey clinical credibility, yet direct enough to function in an in-person representative-physician interaction rather than just in a written promotional format.
The results
- Primary and secondary claim structures adapted from the English TPP source, each of them retaining its rhetorical function (headline claim, contextual support, alternative formulation) in French.
- ANSM regulatory framing applied at the claim level; benefit-risk balance reviewed for each claim before delivery.
- Register calibrated for field-force use: claims adapted to function in spoken representative-physician interactions, not only in written promotional materials.
